Skip to content
10-Q

Quarterly Report

BOSTON SCIENTIFIC CORP BSX

0000885725-26-000033

← back to feed
Filed
May 1, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 1.49B sh
Shares Diluted Q1 2026 · Mar 31, 2026 1.5B sh
Shares Diluted Q1 2026 · Mar 31, 2025 1.49B sh
Capex Q1 2026 · Mar 31, 2026 $177M
Capex Q1 2026 · Mar 31, 2025 $187M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $348M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $541M
Short Term Debt Q1 2026 · Mar 31, 2026 $41M
Short Term Debt Q1 2026 · Dec 31, 2025 $299M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.45B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.97B
Cash And Equivalents Q1 2026 · Mar 31, 2025 $725M
Stockholders Equity Q1 2026 · Mar 31, 2026 $25.86B
Stockholders Equity Q1 2026 · Dec 31, 2025 $24.23B
Current Liabilities Q1 2026 · Mar 31, 2026 $4.57B
Current Liabilities Q1 2026 · Dec 31, 2025 $5.44B
Current Assets Q1 2026 · Mar 31, 2026 $8.68B
Current Assets Q1 2026 · Dec 31, 2025 $8.79B
Total Assets Q1 2026 · Mar 31, 2026 $44.35B
Total Assets Q1 2026 · Dec 31, 2025 $43.67B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.90
Eps Diluted Q1 2026 · Mar 31, 2025 $0.45
Eps Basic Q1 2026 · Mar 31, 2026 $0.90
Eps Basic Q1 2026 · Mar 31, 2025 $0.46
Sga Expense Q1 2026 · Mar 31, 2026 $1.78B
Sga Expense Q1 2026 · Mar 31, 2025 $1.6B
Operating Income Q1 2026 · Mar 31, 2026 $1.1B
Operating Income Q1 2026 · Mar 31, 2025 $921M
Gross Profit Q1 2026 · Mar 31, 2026 $3.61B
Gross Profit Q1 2026 · Mar 31, 2025 $3.21B
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.59B
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.45B
Revenue Q1 2026 · Mar 31, 2026 $5.2B
Revenue Q1 2026 · Mar 31, 2025 $4.66B